Personal tools
  • mobilize, resist, transform
You are here: Home english publications link gmo page 9

 

donate-portlet

 

voices icon

 

page 9

9
  link
  

 

In early 1994, the US Food and Drug Administration (FDA) announced that the ‘Flavr Savr', a new genetically modified tomato produced by Calgene, was as safe as tomatoes bred by conventional means. Thus the Flavr Savr became the first fresh genetically modified crop sold in the world.

Calgene, a small start-up biotech company based in California , genetically modified tomatoes so that they could be picked when ripe and transported without bruising. They believed that the Flavr Savr would have a longer shelf life than conventional tomatoes, and would provide processors and consumers with tastier tomatoes.

The FDA approved the product. More generally, it decided to regulate GM foods in the same way as non-GM foods so they do not require pre-market approval, arguing that the two are the same or substantially equivalent. Nevertheless, there was no scientific evidence that the tomatoes were safe for human consumption. In fact, the FDA ignored the advice of its own scientists who were concerned about studies showing that the GM tomatoes could potentially cause stomach lesions. In one study, gross lesions were observed in 4 out of 20 female rats fed one of the two lines of transgenic tomato. In another study, the rats had both gross and microscopic lesions. The FDA, however, downplayed these findings and did not communicate them to the public.

In 1994, Flavr Savr tomatoes were labeled as GM and sold under the MacGregor's brand name. Initially they sold relatively well, and were available in 2500 stores nationwide by 1995. Ultimately, however, a combination of safety concerns by consumers, the cost of the GM tomatoes (about double the price of ordinary tomatoes), the flavor (not better than non-GM) and the tendency of the tomatoes to bruise led to their withdrawal from the market in 1997.

Ultimately, the world's first commercialized GM crop was a flop. This also led to the demise of Calgene, which had accumulated heavy debts in the development of the tomato. In the end, biotech giant Monsanto bought Calgene, but has never tried to introduce a tomato similar to the doomed Flavr Savr.

source:
Soil Association : www.soilassociation.org


 


Document Actions